TrialJournal of neuro-oncology2009

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.

Marta Santisteban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.